✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
圣和化工
首页 › 产品目录 › 柠檬酸帕克替尼

柠檬酸帕克替尼

CAS 1228923-42-9C34H40N4O10MW 664.7

柠檬酸帕克替尼,CAS 登记号 1228923-42-9,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于有机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。

规格参数

CAS号1228923-42-9
分子式C34H40N4O10
分子量664.7
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域有机化学品
类别有机化学品

用途与场景

有机化学品

包装与供货

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
供货周期现货/按订单安排

文件与支持

每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。

常见问题

在哪里能查到 柠檬酸帕克替尼 的 CAS 号?

本页已列出 柠檬酸帕克替尼 的 CAS 号:1228923-42-9,可与随货 COA 核对。

可以提供哪些规格和包装?

常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。

柠檬酸帕克替尼 一般用在什么产品里?

主要涉及有机化学品。

下单流程是怎样的?

来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。

PubChem 公开数据

Description

Pacritinib citrate · CAS 1228923-42-9 · C34H40N4O10. UNII VJ2PH4NXX7.

Identification

CAS Registry Number1228923-42-9
PubChem CID46216795
Molecular formulaC34H40N4O10
IUPAC name2-hydroxypropane-1,2,3-tricarboxylic acid;(16E)-11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(24),2(27),3,5,8(26),9,11,16,21(25),22-decaene
UNII (FDA)VJ2PH4NXX7

Computed Descriptors

Molecular Weight664.7
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count14
Rotatable Bond Count9
Exact Mass664.27444349
Monoisotopic Mass664.27444349
Topological Polar Surface Area201
Heavy Atom Count48
Formal Charge0
Complexity871

GHS Hazard Classification

Reported hazard statementsH373 (100%)

H373 (100%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]

P260, P319, and P501 (click each P-code to see the statement)

Documented Uses

  • Pacritinib citrate is approved to treat adults with:
  • • Myelofibrosis (a bone marrow disease) that is intermediate or high risk with a very low platelet count, including the following types:
  • • Post-polycythemia vera myelofibrosis.
  • • Post-essential thrombocythemia myelofibrosis.
  • Pacritinib citrate is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that it provides a clinical benefit in these patients.Pacritinib citrate is also being studied in the treatment of other conditions.

Synonyms

Pacritinib citrate; Vonjo; 1228923-42-9; VJ2PH4NXX7; SB1518 CITRATE; SB-1518 CITRATE; UNII-VJ2PH4NXX7; Epjevy; RefChem:58093; Pacritinib (citrate); SB 1518 citrate; Pacritinib citrate [MI]; Pacritinib citrate [WHO-DD]; orb2565590; CHEMBL5095049; CHEBI:231412

Frequently Asked Questions

What are the CAS number and molecular formula of Pacritinib citrate?

CAS 1228923-42-9; molecular formula C34H40N4O10; molecular weight — g/mol.

What other names is Pacritinib citrate known by?

Pacritinib citrate, Vonjo, 1228923-42-9, VJ2PH4NXX7, SB1518 CITRATE, SB-1518 CITRATE.

Is Pacritinib citrate classified as hazardous?

Hazard statements reported: H373.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

同类推荐

获取 柠檬酸帕克替尼 报价

供应商:济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp
鲁ICP备19031700号-1